Low-Versus High-Dose Interferon Alfa-2a in Relapsed Indolent Non-Hodgkin's Lymphoma
Authors: L. A. VANDERMOLE, R. G. STEIS, P. L. DUFFEY, K. A. FOON, J. W. SMITH, J. W. CLARK, K. CONLON, H. C. STEVENSON, W. J. URBA, L. C. HARTMANN, T. WATSON, E. S. JAFFE, D. L. LONGO
Journal: JNCI Journal of the National Cancer Institute (1990)

Journal Article Low-Versus High-Dose Interferon Alfa-2a in Relapsed Indolent Non-Hodgkin's Lymphoma Get access LOUIS A. VANDERMOLE, LOUIS A. VANDERMOLE Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar RONALD G. STEIS, RONALD G. STEIS Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar PATRICIA L. DUFFEY, PATRICIA L. DUFFEY Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar KENNETH A. FOON, KENNETH A. FOON Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar JOHN W. SMITH, JOHN W. SMITH Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar JEFFREY W. CLARK, II, JEFFREY W. CLARK, II Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar KEVIN CONLON, KEVIN CONLON Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar HENRY C. STEVENSON, HENRY C. STEVENSON Biological Response, Modifiers Program, Division of Cancer Treatment,National Cancer Institute, NCI-Frederick Cancer, Research FacilityBethesda, MD Search for other works by this author on: Oxford Academic PubMed Google Scholar WALTER J. URBA, WALTER J. URBA Program Resources, Inc. NCI-Frederick Cance, Research FacilityFrederick ,MD Search for other works by this author on: Oxford Academic PubMed Google Scholar LYNN C. HARTMANN, LYNN C. HARTMANN Program Resources, Inc. NCI-Frederick Cance, Research FacilityFrederick ,MD Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more THELMA WATSON, THELMA WATSON Biological Response, Modifiers Program, Frederick Memorial Hospital, Cancer Treatment Center,Frederick ,MD Search for other works by this author on: Oxford Academic PubMed Google Scholar ELAINE S. JAFFE, ELAINE S. JAFFE Laboratory of Pathology, Division of Cancer, Biology and Diagnosis, National Cancer InstituteBethesda, MN Search for other works by this author on: Oxford Academic PubMed Google Scholar DAN L. LONGO DAN L. LONGO * 2 We thank the BRMP nurses for provoding excellent care to the patients in this study and Ms. Theresa Phillips for secretarial assistance in preparing this manuscript. *Correspondence to : Biological Response Modifiers Program, National Cancer Institute, Frederick Cancer Research Facility, Bldg. 567, Rm. 135, Frederick, MD 21701. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 82, Issue 3, 7 February 1990, Pages 235–238, https://doi.org/10.1093/jnci/82.3.235 Published: 07 February 1990